Abhilash Deo - Publications

Affiliations: 
2015-2021 Imaging Cell Signalling and Therapeutics Lab ACTREC, Mumbai 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Benguigui M, Cooper TJ, Kalkar P, Schif-Zuck S, Halaban R, Bacchiocchi A, Kamer I, Deo A, Manobla B, Menachem R, Haj-Shomaly J, Vorontsova A, Raviv Z, Buxbaum C, Christopoulos P, et al. Interferon-stimulated neutrophils as a predictor of immunotherapy response. Cancer Cell. PMID 38181798 DOI: 10.1016/j.ccell.2023.12.005  0.342
2023 Deo A, Sleeman JP, Shaked Y. The role of host response to chemotherapy: resistance, metastasis and clinical implications. Clinical & Experimental Metastasis. PMID 37999904 DOI: 10.1007/s10585-023-10243-5  0.387
2021 Deo AN, Thorat R, Dhadve AC, De A, Rekhi B, Ray P. IGF1R-α6 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1868: 166282. PMID 34600083 DOI: 10.1016/j.bbadis.2021.166282  0.333
2020 Deo A, Mukherjee S, Rekhi B, Ray P. Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer. Indian Journal of Pathology & Microbiology. 63: S64-S69. PMID 32108633 DOI: 10.4103/IJPM.IJPM_872_19  0.535
2019 Deo A, Chaudhury S, Kannan S, Rekhi B, Maheshwari A, Gupta S, Ray P. IGF1R predicts better survival in high-grade serous epithelial ovarian cancer patients and correlates with hCtr1 levels. Biomarkers in Medicine. PMID 31140856 DOI: 10.2217/bmm-2018-0311  0.482
Show low-probability matches.